Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Adc Therapeutics Sa (ADCT)

Adc Therapeutics Sa (ADCT)
1.1100 x 1 1.3700 x 1
Post-market by (Cboe BZX)
1.2100 +0.0500 (+4.31%) 04/17/25 [NYSE]
1.1100 x 1 1.3700 x 1
Post-market 1.2700 +0.0600 (+4.96%) 19:23 ET
Quote Overview for Thu, Apr 17th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.1400
Day High
1.2400
Open 1.1600
Previous Close 1.1600 1.1600
Volume 165,800 165,800
Avg Vol 373,835 373,835
Stochastic %K 31.47% 31.47%
Weighted Alpha -69.49 -69.49
5-Day Change +0.0900 (+8.04%) +0.0900 (+8.04%)
52-Week Range 1.0500 - 5.1700 1.0500 - 5.1700
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 119,892
  • Shares Outstanding, K 99,084
  • Annual Sales, $ 70,840 K
  • Annual Income, $ -157,850 K
  • EBIT $ -131 M
  • EBITDA $ -127 M
  • 60-Month Beta 1.55
  • Price/Sales 1.62
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 335.94% ( -106.73%)
  • Historical Volatility 74.82%
  • IV Percentile 94%
  • IV Rank 40.92%
  • IV High 806.85% on 11/22/24
  • IV Low 9.74% on 08/16/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 10
  • Volume Avg (30-Day) 25
  • Put/Call OI Ratio 0.10
  • Today's Open Interest 925
  • Open Int (30-Day) 1,052

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.38
  • Number of Estimates 2
  • High Estimate -0.37
  • Low Estimate -0.39
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +32.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0500 +15.24%
on 04/09/25
Period Open: 1.7900
1.8393 -34.21%
on 03/20/25
-0.5800 (-32.40%)
since 03/17/25
3-Month
1.0500 +15.24%
on 04/09/25
Period Open: 1.8300
1.9100 -36.65%
on 03/12/25
-0.6200 (-33.88%)
since 01/17/25
52-Week
1.0500 +15.24%
on 04/09/25
Period Open: 4.9600
5.1700 -76.60%
on 05/06/24
-3.7500 (-75.60%)
since 04/17/24

Most Recent Stories

More News
Insider Purchase: 10% owner at $ADCT (ADCT) Buys 50,000 Shares

Group, LLC Redmile, a 10% owner of $ADCT ($ADCT), bought 50,000 shares of the company on 12-11-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their...

ADCT : 1.2100 (+4.31%)
Insider Sale: 10% owner at $ADCT (ADCT) Sells 25,352 Shares

Group, LLC Redmile, a 10% owner of $ADCT ($ADCT), sold 25,352 shares of the company on 12-04-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.2% of their...

ADCT : 1.2100 (+4.31%)
5 Biotech Stocks Under $10 With Multibagger Potential

As the biotech industry continues to redefine the healthcare landscape, here are five penny biotech stocks poised for meteoric growth in this evolving industry.

$SPX : 5,282.70 (+0.13%)
RZLT : 2.75 (+4.17%)
TRVI : 6.07 (-0.49%)
ELEV : 0.3860 (+16.72%)
CRDL : 1.0100 (unch)
ADCT : 1.2100 (+4.31%)
1 'Strong Buy' Russell 2000 Stock With 188% Upside Potential

As a part of the annual Russell Index reconstitution, this ‘Strong Buy’-rated penny stock is one of the new entrants to the Russell 2000 Index.

MRSN : 0.3547 (+5.63%)
$SPX : 5,282.70 (+0.13%)
ADCT : 1.2100 (+4.31%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC" or the "Company") (NYSE: ADCT). Such investors are...

ADCT : 1.2100 (+4.31%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC" or the "Company") (NYSE: ADCT). Such investors are...

ADCT : 1.2100 (+4.31%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC" or the "Company") (NYSE: ADCT). Such investors are...

ADCT : 1.2100 (+4.31%)
Sobi to present new data at the 2023 EHA congress

/PRNewswire/ -- Sobi® will present data at the EHA (European Haematology Association) hybrid congress taking place in Frankfurt, Germany 8-11 June, 2023,...

ADCT : 1.2100 (+4.31%)
ADC Therapeutics to Host First Quarter 2023 Financial Results Conference Call on May 9, 2023

ADC Therapeutics SA (NYSE: ADCT) today announced that it will host a conference call and live webcast on Tuesday, May 9, 2023 at 8:30 a.m. EDT to report financial results for the first quarter 2023 and...

ADCT : 1.2100 (+4.31%)
PharmaVentures establishes an office in Seoul to enhance access for South Korean biotechs

/PRNewswire/ -- PharmaVentures announces its new office in Korea as part of its continued strategic expansion Headquartered in London, UK, PharmaVentures has...

ADCT : 1.2100 (+4.31%)

Business Summary

ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.

See More

Key Turning Points

3rd Resistance Point 1.3533
2nd Resistance Point 1.2967
1st Resistance Point 1.2533
Last Price 1.2100
1st Support Level 1.1533
2nd Support Level 1.0967
3rd Support Level 1.0533

See More

52-Week High 5.1700
Fibonacci 61.8% 3.5962
Fibonacci 50% 3.1100
Fibonacci 38.2% 2.6238
Last Price 1.2100
52-Week Low 1.0500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro